J A Francisco

873 total citations
9 papers, 679 citations indexed

About

J A Francisco is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, J A Francisco has authored 9 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in J A Francisco's work include Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (2 papers) and T-cell and B-cell Immunology (2 papers). J A Francisco is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (2 papers) and T-cell and B-cell Immunology (2 papers). J A Francisco collaborates with scholars based in United States, Germany and Philippines. J A Francisco's co-authors include George Georgiou, Charles F. Earhart, Brent L. Iverson, R.J. Campbell, Lori Westendorf, Kevin J. Hamblett, Charlotte F. McDonagh, Jamie B. Andreyka, Stephen C. Alley and Paul Carter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Leukemia.

In The Last Decade

J A Francisco

9 papers receiving 651 citations

Peers

Countries citing papers authored by J A Francisco

Since Specialization

Citations

This map shows the geographic impact of J A Francisco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J A Francisco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J A Francisco more than expected).

Fields of papers citing papers by J A Francisco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J A Francisco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J A Francisco. The network helps show where J A Francisco may publish in the future.

Co-authorship network of co-authors of J A Francisco

This figure shows the co-authorship network connecting the top 25 collaborators of J A Francisco. A scholar is included among the top collaborators of J A Francisco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J A Francisco. J A Francisco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Visualization of renal rotenone accumulation after oral administration and in situ detection of kidney injury biomarkers via MALDI mass spectrometry imaging 2024 ·Frontiers in Molecular Biosciences ·(unknown), (unknown), (unknown), (unknown), (unknown), J A Francisco, (unknown), (unknown), Monissa C. Paderes, (unknown), Jonel P. Saludes, Doralyn S. Dalisay	4
2	Inhibitory Effects of B-, C-, and E-Ring-Truncated Deguelin Derivatives Against A549, HCT116, and MCF-7 Cancer Cells 2023 ·ACS Omega ·J A Francisco, Monissa C. Paderes	2
3	Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment 2006 ·Protein Engineering Design and Selection ·Charlotte F. McDonagh, Eileen Turcott, Lori Westendorf, (unknown), Stephen C. Alley, (unknown), Jamie B. Andreyka, Ivan J. Stone, Kevin J. Hamblett, J A Francisco, Paul Carter	182
4	Signaling via the anti-CD30 mAb SGN-30 sensitizes Hodgkin's disease cells to conventional chemotherapeutics 2005 ·Leukemia ·Charles G. Cerveny, (unknown), (unknown), (unknown), Kevin J. Hamblett, Lori Westendorf, (unknown), Joseph M. Petroziello, J A Francisco, Alan F. Wahl	45
5	Agonistic properties and in vivo antitumor activity of the anti-CD40 antibody SGN-14. 2000 ·PubMed ·J A Francisco, (unknown), Dana F. Chace, Clay B. Siegall, (unknown)	36
6	Agonistic activity of a CD40-specific single-chain Fv constructed from the variable regions of mAb G28-5. 1997 ·PubMed ·J A Ledbetter, J A Francisco, Clay B. Siegall, Lisa K. Gilliland, Diane Hollenbaugh, Alejandro Aruffo, Anthony W. Siadak, (unknown), Laura S. Grosmaire, (unknown), T J Brown, (unknown), Robert S. Mittler, Peter A. Kiener, Steven G. Nadler	5
7	Cytokine activation sensitizes human monocytic and endothelial cells to the cytotoxic effects of an anti-CD40 immunotoxin 1996 ·The Journal of Immunology ·J A Francisco, Peter A. Kiener, (unknown), J A Ledbetter, Clay B. Siegall	12
8	Production and fluorescence-activated cell sorting of Escherichia coli expressing a functional antibody fragment on the external surface. 1993 ·Proceedings of the National Academy of Sciences ·J A Francisco, R.J. Campbell, Brent L. Iverson, George Georgiou	190
9	Transport and anchoring of beta-lactamase to the external surface of Escherichia coli. 1992 ·Proceedings of the National Academy of Sciences ·J A Francisco, Charles F. Earhart, George Georgiou	203

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact